Vanguard Group Inc Moderna, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 40,323,750 shares of MRNA stock, worth $1.29 Billion. This represents 0.03% of its overall portfolio holdings.

Number of Shares

40,323,750

Previous 40,226,214 0.24%

Holding current value

$1.29 Billion

Previous $2.69 Billion 37.63%

% of portfolio

0.03%

Previous 0.05%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$36.85 - $63.93 $3.59 Million - $6.24 Million	97,536 Added 0.24%	40,323,750 $1.68 Billion
Q3 2024 Nov 13, 2024	BUY	$63.64 - $125.14 $42.2 Million - $83 Million	663,418 Added 1.68%	40,226,214 $2.69 Billion
Q2 2024 Aug 13, 2024	BUY	$101.21 - $166.61 $53.2 Million - $87.6 Million	525,924 Added 1.35%	39,562,796 $4.7 Billion
Q1 2024 May 10, 2024	BUY	$85.37 - $115.44 $438 Million - $592 Million	5,129,800 Added 15.13%	39,036,872 $4.16 Billion
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $434 Million - $653 Million	6,248,623 Added 22.59%	33,907,072 $3.37 Billion
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $18.9 Million - $24.8 Million	196,012 Added 0.71%	27,658,449 $2.86 Billion
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $7.62 Million - $10.3 Million	-64,312 Reduced 0.23%	27,462,437 $3.34 Billion
Q1 2023 Jul 14, 2023	BUY	$135.66 - $197.02 $63,624 - $92,402	469 Added 0.0%	27,526,749 $4.23 Billion
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $33.1 Million - $48.1 Million	244,107 Added 0.89%	27,526,280 $4.23 Billion
Q4 2022 Feb 10, 2023	SELL	$118.38 - $210.04 $18.9 Million - $33.6 Million	-159,985 Reduced 0.58%	27,282,173 $4.9 Billion
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $24.4 Million - $40.1 Million	-206,299 Reduced 0.75%	27,442,158 $3.25 Billion
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $71.5 Million - $108 Million	610,265 Added 2.26%	27,648,457 $3.95 Billion
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $49.1 Million - $91.3 Million	-388,378 Reduced 1.42%	27,038,192 $4.66 Billion
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $55.4 Million - $90.3 Million	245,159 Added 0.9%	27,426,570 $6.97 Billion
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $1.55 Billion - $3.38 Billion	6,986,507 Added 34.6%	27,181,411 $10.5 Billion
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $2.62 Billion - $4.75 Billion	20,194,904 New	20,194,904 $4.75 Billion

Others Institutions Holding MRNA

# of Institutions

899

Shares Held

239M

Call Options Held

12.1M

Put Options Held

20.8M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $12.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Moderna, Inc. Transaction History